# Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache

> **NCT01540799** · NA · COMPLETED · sponsor: **Autonomic Technologies, Inc.** · enrollment: 80 (estimated)

## Conditions studied

- High Frequency, High Disability Migraine

## Interventions

- **DEVICE:** ATI Neurostimulation System

## Key facts

- **NCT ID:** NCT01540799
- **Lead sponsor:** Autonomic Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2018-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01540799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01540799, "Pathway M-1: Sphenopalatine Ganglion Stimulation for the AcuteTreatment of High Disability Migraine Headache". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01540799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*